Bayer Aktiengesellschaft (ETR:BAYN) Trading 1.6% Higher – Should You Buy?

Bayer Aktiengesellschaft (ETR:BAYN) shares traded up 1.6% during trading on Monday . The company traded as high as €35.92 and last traded at €35.88. 5,741,342 shares traded hands during trading, The stock had previously closed at €35.30.

Bayer Aktiengesellschaft Stock Up 1.6%

The company has a market capitalization of $36.22 billion, a P/E ratio of -41.16, a PEG ratio of 36.39 and a beta of 0.97. The business has a 50 day simple moving average of €29.95 and a 200-day simple moving average of €28.35.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.